Antithrombotic Therapy Not Helpful for COVID-19 Outpatients
Major adverse cardiopulmonary outcomes not reduced with aspirin, apixaban versus placebo for clinically stable COVID-19 outpatients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.